SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Genfit S.A. (GNFT) trades at a trailing P/E of 275.4. Trailing earnings yield is 0.36%.
Criteria proven by this page:
- VALUE (57/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Trailing Earnings Yield 0.36% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $13.00 (+45.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 53/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
57/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GNFT
Valuation Multiples
P/E (TTM)275.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.03
Book Value / Share$0.00
Revenue / Share$1.34
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.36%
Dividend Yield0.00%
Analyst Target$13.00 (+45.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.69 |
$527K |
$-17.14M |
-3251.4% |
| 2016 |
$-1.25 |
$284K |
$-33.67M |
-11854.6% |
| 2017 |
$-1.88 |
$118K |
$-58.6M |
-49664.4% |
| 2018 |
$-2.55 |
$69K |
$-79.52M |
-115247.8% |
| 2019 |
$-1.76 |
$30.84M |
$-65.15M |
-211.2% |
| 2020 |
$-2.60 |
$765K |
$-101.22M |
-13231.5% |
| 2021 |
$1.21 |
$80.07M |
$67.26M |
84% |
| 2022 |
$-0.48 |
$20.2M |
$-23.72M |
-117.5% |
| 2023 |
$-0.58 |
$28.57M |
$-28.89M |
-101.2% |
| 2024 |
$0.03 |
$67M |
$1.51M |
2.2% |
